1-3 of 3
Mara De Martino
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Translating Science into Survival: Report on the Sixth International Cancer Immunotherapy Conference

Mara De Martino, Neha J. Pancholi, Arthur N. Brodsky
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (2): 145–149.
https://doi.org/10.1158/2326-6066.CIR-22-0987
Published: 03 February 2023
View article titled, Translating Science into Survival: Report on the Sixth International Cancer Immunotherapy Conference
Open the PDF for Translating Science into Survival: Report on the Sixth International Cancer Immunotherapy Conference in another window
Journal Articles

Activin A Promotes Regulatory T-cell–Mediated Immunosuppression in Irradiated Breast Cancer

Mara De Martino, Camille Daviaud, Julie M. Diamond, Jeffrey Kraynak, Amandine Alard, Silvia C. Formenti, Lance D. Miller, Sandra Demaria, Claire Vanpouille-Box
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (1): 89–102.
https://doi.org/10.1158/2326-6066.CIR-19-0305
Published: 04 January 2021
View article titled, Activin A Promotes Regulatory T-cell–Mediated Immunosuppression in Irradiated Breast Cancer
Open the PDF for Activin A Promotes Regulatory T-cell–Mediated Immunosuppression in Irradiated Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B25: Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy

Mara De Martino, Mercedes Tkach, María F. Mercogliano, Mauro E. Cenciarini, María F. Chervo, Cecilia J. Proietti, Patricia V. Elizalde, Eliane Piaggio, Roxana Schillaci
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (4_Supplement): B25.
https://doi.org/10.1158/2326-6074.TUMIMM18-B25
Published: 01 April 2020
View article titled, Abstract B25: Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy